http://www.maps.org/images/mapslogo-sm.gif http://www.maps.org/ 50 50 Psychedelic research news http://www.maps.org/ psychedelic research news en-us editor@maps.org webmaster@maps.org Sat, 6 Sep 2008 23:22:18 CST New Scientist, a preeminent science weekly, printed a compelling interview with MAPS president Rick Doblin. Journalist Arran Frood noted that Doblin “kept the faith” in spite of bureaucratic obstacles to psychedelic research.]]> Calgary Herald published an article titled "Tripping Into Mental Health," which is an enthusiastic response to Andrew Feldmár’s editorial in the Guardian. Kevin Brooker, the author, credits MAPS with opening the doors to MDMA research. ]]> wrote an editorial for the UK's Guardian about the numerous healing potentials of psychedelic psychotherapy. ]]> Herald Tribune from Sarasota, Florida, home to MAPS President Rick Doblin's Alma Mater New College, featured a article on Doblin, and MAPS' MDMA/PTSD research. Former acting director of NIDA Glen Hanson tries to detract the possibility of MDMA ever being approved as a prescription medicine, but Doblin counters that pre-existing MDMA data will expedite the process of approval by the FDA. NORML's executive director Alan St. Pierre likens Doblin to a mythical deity, "Rick is Pan," St. Pierre says. "He's Pan with the fife. And I've got to admit, I'm not immune to that at all."]]> telegraph.co.uk (Permalink) published a straightforward article about the resurgence of psychedelic research. Graham Tibbet's piece Drugs like LSD and Ecstasy could help terminally ill, discusses the MAPS sponsored LSD study in Switzerland, MDMA/PTSD research, Grobs Harbor-UCLA psilocybin research, and Grifiths psilocybin research. ]]>